Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Decreased serum L-arginine and L-citrulline levels in major depression.

Hess S, Baker G, Gyenes G, Tsuyuki R, Newman S, Le Melledo JM.

Psychopharmacology (Berl). 2017 Nov;234(21):3241-3247. doi: 10.1007/s00213-017-4712-8. Epub 2017 Aug 13.

PMID:
28803324
2.

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.

Gong IY, Goodman SG, Brieger D, Gale CP, Chew DP, Welsh RC, Huynh T, DeYoung JP, Baer C, Gyenes GT, Udell JA, Fox KAA, Yan AT; Canadian GRACE/GRACE-2 and CANRACE Investigators.

Int J Cardiol. 2017 Oct 1;244:24-29. doi: 10.1016/j.ijcard.2017.06.055. Epub 2017 Jun 15.

PMID:
28645803
3.

The Effect of Nurse Practitioner-Led Intervention in Diabetes Care for Patients Admitted to Cardiology Services.

Li S, Roschkov S, Alkhodair A, O'Neill BJ, Chik CL, Tsuyuki RT, Gyenes GT.

Can J Diabetes. 2017 Feb;41(1):10-16. doi: 10.1016/j.jcjd.2016.06.008. Epub 2016 Sep 19.

PMID:
27658765
4.

Effect of Cardiac Rehabilitation on South Asian Individuals With Cardiovascular Disease: Results From the APPROACH Registry.

Sharma R, Norris CM, Gyenes G, Senaratne M, Bainey KR.

Can J Cardiol. 2016 Oct;32(10 Suppl 2):S397-S402. doi: 10.1016/j.cjca.2016.05.012. Epub 2016 May 27.

PMID:
27692121
5.

In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure.

Zhang H, Goodman SG, Yan RT, Steg PG, Kornder JM, Gyenes GT, Grondin FR, Brieger D, DeYoung JP, Gallo R, Yan AT; Canadian GRACE and CANRACE Investigators.

Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):214-22. doi: 10.1177/2048872615574109. Epub 2015 Mar 12.

PMID:
25766512
6.

Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project.

Stafinski T, Menon D, Nardelli A, Bakal J, Ezekowitz J, Tymchak W, Welsh R, Gyenes G, Armstrong PW.

Am Heart J. 2015 Jan;169(1):122-31.e22. doi: 10.1016/j.ahj.2014.10.002. Epub 2014 Oct 13.

PMID:
25497257
7.

Inching closer to a solution: sorting out the optimal strategy for STEMI patients with multi-vessel coronary artery disease.

Gyenes GT, Welsh RC.

Can J Cardiol. 2014 Dec;30(12):1501-2. doi: 10.1016/j.cjca.2014.10.015. Epub 2014 Oct 17. No abstract available.

PMID:
25475452
8.

In regard to Girinsky et al.

Gyenes GT.

Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):931. doi: 10.1016/j.ijrobp.2014.04.003. No abstract available.

PMID:
24969805
9.

IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses.

Liu J, Zhan W, Kim CJ, Clayton K, Zhao H, Lee E, Cao JC, Ziegler B, Gregor A, Yue FY, Huibner S, MacParland S, Schwartz J, Song HH, Benko E, Gyenes G, Kovacs C, Kaul R, Ostrowski M.

PLoS One. 2014 Feb 21;9(2):e89236. doi: 10.1371/journal.pone.0089236. eCollection 2014.

10.

Use and timing of coronary angiography and associated in-hospital outcomes in Canadian non-ST-segment elevation myocardial infarction patients: insights from the Canadian Global Registry of Acute Coronary Events.

Gyenes GT, Yan AT, Tan M, Welsh RC, Fox KA, Grondin FR, Deyoung JP, Rose BF, Gallo R, Kornder JM, Wong GC, Goodman SG; Canadian Global Registry of Acute Coronary Events (GRACE/GRACE(2)); Canadian Registry of Acute Coronary Events (CANRACE) Investigators.

Can J Cardiol. 2013 Nov;29(11):1429-35. doi: 10.1016/j.cjca.2013.04.035. Epub 2013 Jul 30.

PMID:
23910228
11.

In regard to Mast et al.

Gyenes GT, Butler CR.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):579. doi: 10.1016/j.ijrobp.2012.06.027. No abstract available.

PMID:
23374992
12.

Percutaneous revascularization improves outcomes in patients with prior coronary artery bypass surgery.

Gyenes G, Norris CM, Graham MM; APPROACH Investigators.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E148-54. doi: 10.1002/ccd.24711. Epub 2012 Dec 3.

PMID:
23208677
13.

HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.

Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, Rieger M, Muscat-King S, Loudon PT, Stanley C, Holditch SJ, Wong JC, Clayton K, Duan E, Song H, Xu Y, SenGupta D, Tandon R, Sacha JB, Brockman MA, Benko E, Kovacs C, Nixon DF, Ostrowski MA.

J Clin Invest. 2012 Dec;122(12):4473-89. doi: 10.1172/JCI64560. Epub 2012 Nov 12.

14.

Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).

Bajaj RR, Goodman SG, Yan RT, Bagnall AJ, Gyenes G, Welsh RC, Eagle KA, Brieger D, Ramanathan K, Grondin FR, Yan AT; Canadian GRACE and CANRACE Investigators.

Am J Cardiol. 2013 Jan 15;111(2):202-7. doi: 10.1016/j.amjcard.2012.09.018. Epub 2012 Nov 1.

PMID:
23122889
15.

Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.

Jones RB, John VM, Hunter DV, Martin E, Mujib S, Mihajlovic V, Burgers PC, Luider TM, Gyenes G, Sheppard NC, Sengupta D, Tandon R, Yue FY, Benko E, Kovacs C, Nixon DF, Ostrowski MA.

Clin Vaccine Immunol. 2012 Feb;19(2):288-92. doi: 10.1128/CVI.05583-11. Epub 2011 Dec 28.

16.

Frequency of intensive statin therapy in patients with acute coronary syndrome admitted to a tertiary care center.

Shiu JR, Pearson GJ, Charrois TL, Gyenes G, Koshman SL.

Am J Cardiol. 2012 Jan 1;109(1):1-5. doi: 10.1016/j.amjcard.2011.07.064. Epub 2011 Oct 6.

PMID:
21981973
17.

Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation.

Welsh RC, Cockfield SM, Campbell P, Hervas-Malo M, Gyenes G, Dzavik V.

Transplantation. 2011 Jan 27;91(2):213-8. doi: 10.1097/TP.0b013e3181ff4f61.

PMID:
21048531
18.

HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.

Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, Gyenes G, Wong D, Klein MB, Saeed S, Benko E, Kovacs C, Kaul R, Ostrowski MA.

Eur J Immunol. 2010 Sep;40(9):2493-505. doi: 10.1002/eji.201040340.

19.

Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease.

Lee TC, Goodman SG, Yan RT, Grondin FR, Welsh RC, Rose B, Gyenes G, Zimmerman RH, Brossoit R, Saposnik G, Graham JJ, Yan AT; Canadian Acute Coronary Syndromes I and II, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Acute Coronary Events (CANRACE) Investigators.

Am J Cardiol. 2010 Apr 15;105(8):1083-9. doi: 10.1016/j.amjcard.2009.12.005. Epub 2010 Feb 20.

PMID:
20381657
20.

Pericardial tamponade in a patient with inactive ulcerative colitis.

Rezaie A, Wong K, Gyenes G.

Case Rep Med. 2010;2010:352417. doi: 10.1155/2010/352417. Epub 2010 Feb 28.

21.

Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.

Banihashemi B, Goodman SG, Yan RT, Welsh RC, Mehta SR, Montalescot G, Kornder JM, Wong GC, Gyenes G, Steg PG, Yan AT; Global Registry of Acute Coronary Events (GRACE/GRACE(2)) Investigators.

Am Heart J. 2009 Dec;158(6):917-24. doi: 10.1016/j.ahj.2009.09.016.

PMID:
19958857
22.

Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutations.

Jones RB, Yue FY, Gu XX, Hunter DV, Mujib S, Gyenes G, Mason RD, Mohamed R, MacDonald KS, Kovacs C, Ostrowski MA.

J Virol. 2009 Sep;83(17):8722-32. doi: 10.1128/JVI.00433-09. Epub 2009 Jun 24.

23.

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.

Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, Sassi A, Loutfy M, Halpenny R, Persad D, Spotts G, Hecht FM, Chun TW, McCune JM, Kaul R, Rini JM, Nixon DF, Ostrowski MA.

J Exp Med. 2008 Nov 24;205(12):2763-79. doi: 10.1084/jem.20081398. Epub 2008 Nov 10.

24.

Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections.

Sadek M, Yue FY, Lee EY, Gyenes G, Jones RB, Hoffstein V, Munoz DG, Fong I, Ostrowski M.

Clin Vaccine Immunol. 2008 Oct;15(10):1580-9. doi: 10.1128/CVI.00173-08. Epub 2008 Aug 13. Review.

25.

Should all patients with asymptomatic but significant (>50%) left main coronary artery stenosis undergo surgical revascularization?

Gyenes GT, Ghali WA.

Circulation. 2008 Jul 22;118(4):422-5. doi: 10.1161/CIRCULATIONAHA.107.743914. Review. No abstract available.

26.

Late cardiac morbidity and mortality in early-stage breast cancer patients after breast-conservation treatment.

Gyenes G.

J Clin Oncol. 2007 Jun 10;25(17):2489; author reply 2489-90. No abstract available.

PMID:
17557964
27.

The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic.

Pearson GJ, Francis GA, Romney JS, Gilchrist DM, Opgenorth A, Gyenes GT.

Can J Cardiol. 2006 Sep;22(11):939-45.

28.

The prognostic importance of nonsignificant left main coronary artery disease in patients undergoing percutaneous coronary intervention.

Gyenes G, Shrive FM, Graham MM, Ghali WA, Knudtson ML; APPROACH Investigators.

J Am Coll Cardiol. 2006 Jul 18;48(2):276-80. Epub 2006 Jun 21.

29.

In regards to Marks et al. on radiation therapy-associated cardiac perfusion defects, (Int J Radiat Oncol Biol Phys) 2005;63:214-223.

Gyenes G.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1287; author reply 1287-8. No abstract available.

PMID:
16504767
30.

Angiotensin receptor blockers and risk of myocardial infarction: systematic review.

McDonald MA, Simpson SH, Ezekowitz JA, Gyenes G, Tsuyuki RT.

BMJ. 2005 Oct 15;331(7521):873. Epub 2005 Sep 23. Review.

31.

The effects of newer antidepressants on low-density lipoprotein cholesterol levels.

Le Mellédo JM, del Pilar Castillo Abadia M, Newman S, Bailey D, Tsuyuki R, Gyenes G.

J Clin Psychiatry. 2004 Jul;65(7):1017-8; author reply 1018. No abstract available.

PMID:
15291694
32.

Radiation therapy and risk of cardiovascular disease.

Gyenes G, Gyenes G.

JAMA. 2004 Jul 28;292(4):434; author reply 434. No abstract available.

PMID:
15280340
33.

[Contribution to the subject "Chronic pericarditis in Hodgkin disease"].

Gyenes G.

Orv Hetil. 2003 Dec 7;144(49):2443-4; author reply 2444. Hungarian. No abstract available.

PMID:
14725212
34.

Successful treatment of a saphenous vein graft pseudoaneurysm with PTFE-covered JoStents.

Gyenes G, Lazzam C, Feindel C, Roth SL.

Can J Cardiol. 2003 Apr;19(5):569-71.

PMID:
12717494
35.
36.

Radiation-induced ischemic heart disease in breast cancer--a review.

Gyenes G.

Acta Oncol. 1998;37(3):241-6. Review.

PMID:
9677094
37.

Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer.

Gagliardi G, Lax I, Söderström S, Gyenes G, Rutqvist LE.

Radiother Oncol. 1998 Jan;46(1):63-71.

PMID:
9488129
38.

Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy.

Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE.

J Clin Oncol. 1997 Apr;15(4):1348-53.

PMID:
9193326
39.

Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy.

Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE.

Eur J Nucl Med. 1997 Mar;24(3):286-92.

PMID:
9143466
40.

[The history of radiation therapy in Hungary].

Gyenes G.

Orv Hetil. 1996 Nov 10;137(45):2547. Hungarian. No abstract available.

PMID:
8999401
41.

Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study.

Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE.

Int J Radiat Oncol Biol Phys. 1996 Nov 1;36(4):899-905.

PMID:
8960519
42.

Radiation-induced cardiac disease.

Gyenes G, Fornander T, Rutqvist LE.

Am Heart J. 1996 Jun;131(6):1236-8. No abstract available.

PMID:
8644615
43.

[Heart disease caused by radiation].

Gyenes G, Bajcsay A.

Orv Hetil. 1994 Aug 28;135(35):1907-12. Review. Hungarian.

PMID:
8072762
44.

Morbidity of ischemic heart disease in early breast cancer 15-20 years after adjuvant radiotherapy.

Gyenes G, Fornander T, Carlens P, Rutqvist LE.

Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1235-41.

PMID:
8175411
45.

Prinzmetal's angina following postoperative adjuvant radiotherapy for right-sided breast cancer.

Gyenes G, Fornander T, Carlens P, Velander M, Rutqviśt LE.

Acta Oncol. 1994;33(6):706-8. No abstract available.

PMID:
7946453
46.

[The position of the National Association of Country Physicians on the "Activity Program"].

Gyenes G.

Orv Hetil. 1992 Feb 25;133(8):515-7. Hungarian. No abstract available.

PMID:
1542516
47.
48.

[Cardiologic side effects of therapeutic irradiation of breast cancer--early results].

Gyenes G, Faragó K.

Orv Hetil. 1990 Dec 2;131(48):2641-6. Review. Hungarian.

PMID:
2263352
49.

Radiotherapy alone or in combination with surgery in the management of stage III breast cancer.

Fodor J, Svastics E, Gyenes G, Besznyák I.

Acta Chir Hung. 1988;29(3):287-97.

PMID:
3239328
50.

Prognostic significance of residual disease after radiation therapy of stage III breast cancer.

Fodor J, Tóth J, Szentirmay Z, Gyenes G.

Radiother Oncol. 1987 Sep;10(1):17-22.

PMID:
3671768

Supplemental Content

Loading ...
Support Center